Skip to content

Clinical trials

Angiomyolipoma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Angiomyolipoma Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20081
20091
20121
20161
20183
20193
20231
20242
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Active, not recruiting4
Unknown status2
Recruiting1
Terminated1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals4
Assistance Publique - Hôpitaux de Paris1
Biorek S.R.L.1
Botkin Hospital1
CENTOGENE GmbH Rostock1
Chang Gung Memorial Hospital1
Dana-Farber Cancer Institute1
Fluidx Medical Technology, Inc.1
Fudan University1
Fundacio Puigvert1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Angiomyolipoma15
Tuberous Sclerosis7
Lymphangioleiomyomatosis5
Carcinoma, Renal Cell3
Perivascular Epithelioid Cell Neoplasms3
Astrocytoma2
Kidney Neoplasms2
Neoplasms2
Adenoma, Oxyphilic1
Basal Cell Carcinoma1

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.